Heart failure is a major health concern in patients with type 2 diabetes. While the focus of prevention in type 2 diabetes is on obesity, many people with type 2 diabetes are not overweight and it is poorly understood why lean people develop type 2 diabetes and how exactly this should be addressed.

This exciting PhD opportunity is in partnership with the American worldwide consumer product company Colgate-Palmolive, in an emerging R&D area of developing oral formulations for individuals with diabetes.

Prognostic models can be used in health care to predict the probability of an event happening to an individual. For example, knowing that a patient is at high risk of developing type 2 diabetes might change the way they are treated in order to try and prevent or delay this happening.

Aim. To evaluate the impact of an evidence-based intervention incorporating structured education and behaviour change tools supported by lifestyle behaviour coaches on the management of type 2 diabetes.